OBJECTIVE: Homeostasis Model Assessment (HOMA index) is predictive of insulin sensitivity in normal and diabetic patients. This study was designed to see if insulin resistance in hypertensives, measured using the HOMA index, differs, based on salt sensitivity, renin status and sodium intake. METHODS: Fasting insulin and glucose were determined in subsets of 426 essential hypertensives, and normotensives. HOMA was calculated as fasting glucose (mmol) x fasting insulin (muU/ml)/22.5. RESULTS: Four hundred and twenty-six essential hypertensives and normotensives from four HERMES centers form the basis of this report. There was no difference in the HOMA index between hypertensives and normotensives (P= 0.291) or between hypertensives grouped according to blood pressure salt sensitivity (P = 0.153). However, when essential hypertensives were subgrouped by renin status, the low-renin group had significantly lower (P< 0.01) HOMA index than the normal/high-renin group. When normal/high-renin group was divided into modulators and non-modulators, the nonmodulators had significantly higher HOMA index (P< 0.001) than other hypertensive subsets. The effect of sodium intake on the HOMA index was significant only for non-modulators (P< 0.002), with salt restriction increasing insulin resistance. CONCLUSION: Insulin sensitivity differs among subsets of essential hypertension, non-modulators being most insulin resistant and the low-renin subset insulin sensitive. Salt restriction might have an adverse effect on insulin sensitivity in non-modulators. The reduction in cardiovascular risk seen in low-renin hypertensives may be related to their increased insulin sensitivity; in contrast, the clustering of cardiovascular risk factors seen in nonmodulators may be due to increased insulin resistance.
OBJECTIVE: Homeostasis Model Assessment (HOMA index) is predictive of insulin sensitivity in normal and diabeticpatients. This study was designed to see if insulin resistance in hypertensives, measured using the HOMA index, differs, based on salt sensitivity, renin status and sodium intake. METHODS: Fasting insulin and glucose were determined in subsets of 426 essential hypertensives, and normotensives. HOMA was calculated as fasting glucose (mmol) x fasting insulin (muU/ml)/22.5. RESULTS: Four hundred and twenty-six essential hypertensives and normotensives from four HERMES centers form the basis of this report. There was no difference in the HOMA index between hypertensives and normotensives (P= 0.291) or between hypertensives grouped according to blood pressure salt sensitivity (P = 0.153). However, when essential hypertensives were subgrouped by renin status, the low-renin group had significantly lower (P< 0.01) HOMA index than the normal/high-renin group. When normal/high-renin group was divided into modulators and non-modulators, the nonmodulators had significantly higher HOMA index (P< 0.001) than other hypertensive subsets. The effect of sodium intake on the HOMA index was significant only for non-modulators (P< 0.002), with salt restriction increasing insulin resistance. CONCLUSION:Insulin sensitivity differs among subsets of essential hypertension, non-modulators being most insulin resistant and the low-renin subset insulin sensitive. Salt restriction might have an adverse effect on insulin sensitivity in non-modulators. The reduction in cardiovascular risk seen in low-reninhypertensives may be related to their increased insulin sensitivity; in contrast, the clustering of cardiovascular risk factors seen in nonmodulators may be due to increased insulin resistance.
Authors: Luminita H Pojoga; Patricia C Underwood; Mark O Goodarzi; Jonathan S Williams; Gail K Adler; Xavier Jeunemaitre; Paul N Hopkins; Benjamin A Raby; Jessica Lasky-Su; Bei Sun; Jinrui Cui; Xiuqing Guo; Kent D Taylor; Yii-Der Ida Chen; Anny Xiang; Leslie J Raffel; Thomas A Buchanan; Jerome I Rotter; Gordon H Williams Journal: J Clin Endocrinol Metab Date: 2011-05-25 Impact factor: 5.958
Authors: R Baudrand; C G Lian; B Q Lian; V Ricchiuti; T M Yao; J Li; G H Williams; G K Adler Journal: Nutr Metab Cardiovasc Dis Date: 2013-10-12 Impact factor: 4.222
Authors: Sheena M Patel; Paul Cobb; Sharon Saydah; Xuanping Zhang; Janet M de Jesus; Mary E Cogswell Journal: J Nutr Date: 2015-01-21 Impact factor: 4.798
Authors: W Scott Watkins; Steven C Hunt; Gordon H Williams; Whitney Tolpinrud; Xavier Jeunemaitre; Jean-Marc Lalouel; Lynn B Jorde Journal: J Hypertens Date: 2010-01 Impact factor: 4.844
Authors: Anand Vaidya; Rhonda Bentley-Lewis; Xavier Jeunemaitre; Gail K Adler; Jonathan S Williams Journal: Am J Hypertens Date: 2009-03-05 Impact factor: 2.689
Authors: Anand Vaidya; Patricia C Underwood; Paul N Hopkins; Xavier Jeunemaitre; Claudio Ferri; Gordon H Williams; Gail K Adler Journal: Hypertension Date: 2013-02-11 Impact factor: 10.190
Authors: Patricia C Underwood; Bindu Chamarthi; Jonathan S Williams; Anand Vaidya; Rajesh Garg; Gail K Adler; Marissa P Grotzke; Gitana Staskus; Devendra Wadwekar; Paul N Hopkins; Claudio Ferri; Anthony McCall; Donald McClain; Gordon H Williams Journal: J Clin Endocrinol Metab Date: 2012-08-03 Impact factor: 5.958